Title |
Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
|
---|---|
Published in |
BMC Infectious Diseases, April 2012
|
DOI | 10.1186/1471-2334-12-83 |
Pubmed ID | |
Authors |
Santiago Grau, Rafael de la Cámara, Francisco J Sabater, Isidro Jarque, Enric Carreras, Miguel A Casado, Miguel A Sanz |
Abstract |
We evaluated the cost-effectiveness of posaconazole compared with standard azole therapy (SAT; fluconazole or itraconazole) for the prevention of invasive fungal infections (IFI) and the reduction of overall mortality in high-risk neutropenic patients with acute myelogenous leukaemia (AML) or myelodysplastic syndromes (MDS). The perspective was that of the Spanish National Health Service (NHS). |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Spain | 1 | 2% |
Italy | 1 | 2% |
Brazil | 1 | 2% |
Unknown | 46 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 11 | 22% |
Other | 8 | 16% |
Student > Master | 7 | 14% |
Student > Ph. D. Student | 4 | 8% |
Lecturer > Senior Lecturer | 4 | 8% |
Other | 12 | 24% |
Unknown | 4 | 8% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 50% |
Nursing and Health Professions | 4 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Agricultural and Biological Sciences | 2 | 4% |
Other | 3 | 6% |
Unknown | 11 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2012.
All research outputs
#17,656,152
of 22,664,267 outputs
Outputs from BMC Infectious Diseases
#5,064
of 7,636 outputs
Outputs of similar age
#120,274
of 161,135 outputs
Outputs of similar age from BMC Infectious Diseases
#67
of 95 outputs
Altmetric has tracked 22,664,267 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,636 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,135 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.